Angion Biomedica Corp.

NASDAQ: ANGN · Real-Time Price · USD
1.00
0.00 (0.00%)
At close: Jun 01, 2023, 10:00 PM

Angion Biomedica Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
18.35M 17.62M 26.02M 3.42M 14.84M 21.68M 29.22M 50.49M 55.14M 63.37M 73M 88.76M 102.74M 117.31M 130.46M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a 150K 874K 874K 865K 732K 723K 862K 843K 877K
Other Long-Term Assets
1.3M 1.3M 1.29M 2.32M 3.52M 3.52M 864K 61K 75K 86K 78K 106K 33K 38K 38K
Receivables
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a 1.02M 392K 1.2M 2.05M 2.76M -1.67M n/a n/a n/a
Other Current Assets
2.58M 3.08M 4.63M 3.26M 5.09M 4.54M 11.41M 943K 1.54M 2.51M 3.24M 2.49M 1.66M 2.39M 3.04M
Total Current Assets
20.93M 20.69M 30.65M 6.69M 19.93M 26.23M 40.63M 51.43M 56.68M 65.89M 76.24M 91.25M 104.39M 119.7M 133.5M
Property-Plant & Equipment
5.91M 6.19M 6.45M 6.74M 7.54M 7.87M 126K 425K 3.69M 3.98M 4.21M 4.44M 4.65M 4.78M 4.79M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
7.21M 7.49M 7.74M 9.06M 11.06M 11.39M 1.14M 1.36M 4.64M 4.93M 5.02M 5.27M 5.55M 5.66M 5.7M
Total Assets
28.14M 28.18M 38.39M 15.75M 30.99M 37.62M 41.77M 52.79M 61.32M 70.81M 81.26M 96.51M 109.94M 125.36M 139.2M
Account Payables
4.04M 1.04M 1.98M 1.05M 4.41M 4.26M 692K 2.72M 2.22M 2.66M 3.43M 4.71M 7.68M 9.31M 6.69M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a 4.09M 653K 2.3M 3.66M 5.18M 3.79M
Short-Term Debt
926K 901K 877K 854K 938K 985K 227K 1.06M 1.03M 1M 978K 894K 870K 847K 1.68M
Other Current Liabilities
6.45M 9.58M 6.16M 5.68M 6.14M 2.35M 1.11M 2.59M 4.93M 4.12M 5.32M 3.39M 5.74M 5.19M 4.81M
Total Current Liabilities
11.41M 11.52M 9.02M 7.58M 11.49M 7.6M 2.03M 6.37M 8.18M 7.78M 10.38M 11.3M 17.95M 20.52M 16.96M
Long-Term Debt
4.87M 5.11M 5.34M 5.57M 6.21M 6.42M 70K 2.65M 2.92M 3.19M 3.46M 3.48M 3.71M 3.93M 4.15M
Other Long-Term Liabilities
2.96M 22.86M 43.02M 4.25M n/a 46K n/a n/a n/a 81K 220K 235K n/a n/a n/a
Total Long-Term Liabilities
7.83M 27.97M 48.35M 9.82M 6.21M 6.46M 70K 2.65M 2.92M 3.27M 3.67M 3.71M 27.48M 27.65M 29.79M
Total Liabilities
19.24M 39.49M 57.37M 17.4M 17.7M 14.06M 2.1M 9.02M 11.11M 11.05M 14.06M 15.01M 45.43M 48.17M 46.76M
Total Debt
5.79M 6.01M 6.21M 6.42M 7.15M 7.4M 297K 3.71M 3.96M 4.2M 4.43M 4.37M 4.58M 4.78M 5.83M
Common Stock
160K 110K 108K 103K 84K 84K 301K 301K 301K 301K 300K 300K 304K 303K 300K
Retained Earnings
-205.31M -194.1M -180.1M -161.26M -133.25M -122.6M -258.48M -253.94M -247.5M -238.51M -229.38M -215.13M -230.03M -214.32M -197.25M
Comprehensive Income
-144K -175K -202K -238K -25K -2K 165K 86K 302K 98K -199K -103K -73K -219K -287K
Shareholders Equity
8.9M -11.31M -18.99M -1.65M 13.29M 23.56M 39.67M 43.77M 50.21M 59.76M 67.2M 81.51M 64.51M 77.19M 92.44M
Total Investments
n/a n/a n/a n/a n/a n/a 150K 874K 874K 865K 732K 723K 862K 843K 877K